Swiss National Bank Has $2.41 Million Stock Holdings in Pediatrix Medical Group, Inc. $MD

Swiss National Bank lowered its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 1.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 166,300 shares of the company’s stock after selling 2,600 shares during the period. Swiss National Bank owned approximately 0.19% of Pediatrix Medical Group worth $2,410,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. GAMMA Investing LLC increased its position in Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock valued at $37,000 after buying an additional 1,765 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of Pediatrix Medical Group by 218.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company’s stock valued at $98,000 after acquiring an additional 5,104 shares in the last quarter. Squarepoint Ops LLC bought a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at approximately $132,000. Sherbrooke Park Advisers LLC acquired a new position in shares of Pediatrix Medical Group during the fourth quarter worth approximately $136,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new position in shares of Pediatrix Medical Group in the 1st quarter worth $159,000. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Up 5.1%

Pediatrix Medical Group stock opened at $16.9730 on Friday. Pediatrix Medical Group, Inc. has a fifty-two week low of $10.06 and a fifty-two week high of $17.67. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80. The firm’s 50-day simple moving average is $13.76 and its 200 day simple moving average is $13.93. The stock has a market cap of $1.48 billion, a PE ratio of 13.16 and a beta of 1.21.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The firm had revenue of $468.84 million for the quarter, compared to analysts’ expectations of $464.37 million. During the same quarter last year, the firm earned $0.34 EPS. The company’s quarterly revenue was down 7.1% compared to the same quarter last year. Research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have weighed in on MD shares. UBS Group raised their price objective on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the company a “neutral” rating in a research note on Thursday, August 14th. Zacks Research upgraded shares of Pediatrix Medical Group to a “strong-buy” rating in a report on Monday, August 11th. Finally, Macquarie lifted their price target on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an “outperform” rating in a research note on Thursday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $16.75.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.